TRI-IODOTHYROACETIC ACID (TRIAC) (Emcitate®)
Clinical Indication
Allan-Herndon Dudley syndrome associated with MCT-8 deficiency
Comments
Reviewed by TAS 22nd June 2021
Date of classification
July 2021
Do not prescribe
Drugs not recommended for use in LLR because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.